Barclays restated their equal weight rating on shares of GSK (LON:GSK – Free Report) in a research note issued to investors on Monday morning, MarketBeat reports. They currently have a GBX 1,725 ($21.83) price objective on the stock. A number of other analysts have also recently commented on GSK. Shore Capital reiterated a buy rating […]